Pharma Compliance DK ApS: Financial statements 2024
CVR: 43691449
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma Compliance DK ApS (CVR 43691449) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 1,359,073 and a net result of DKK 429,927 compared with DKK 459,890 the year before. That is a decrease of 4.6% compared with the year before. The profit margin was 31.6%. Equity in the 2024 report amounted to DKK 929,817. The solvency ratio was 83.6%.
- Revenue
- DKK 1,359,073
- Gross Profit
- DKK 1,263,316
- Profit/Loss
- DKK 429,927
- Equity
- DKK 929,817
- Total Assets
- DKK 1,112,593
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 1.4M | 1.3M | 430K | 930K | - |
| 2023 | 1.4M | 1.3M | 460K | 500K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 12, 2024, Pharma Analytica DK holding ApS is registered as an owner of Pharma Compliance DK ApS with an ownership share of 100%.
Pharma Compliance DK ApS has published its annual report for 2023. Revenue came to DKK 1,424,796, and the net result was DKK 459,890.
About Pharma Compliance DK ApS
Pharma Compliance DK ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Iskandar Ali Khan Hussain. The company is owned by Pharma Analytica DK holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,763,878 and a net result of DKK 984,131 compared with DKK 429,927 the year before. Equity in the 2025 report amounted to DKK 1,882,048.